Jing Zheng, Jianya Zhou, Yanping Zhu, Qian Shen, Jianying Zhou
Oncology Research, Vol.25, No.4, pp. 545-550, 2017, DOI:10.3727/096504016X14801968368898
Abstract Pancreatic metastasis from non-small cell lung cancer (NSCLC) is usually asymptomatic or presents with
abdominal pain, acute pancreatitis, or jaundice. A lung primary is associated with worse survival compared to
pancreatic metastases from other organs. Surgical treatment of solitary metastasis to the pancreas from NSCLC
has been reviewed in several studies, one of which had a notable disease-free interval. To our knowledge, there
are no prior reports of targeted therapy of pancreatic metastasis of NSCLC followed by a significant response.
Herein we report the case of a 31-year-old female with a solitary pancreatic metastasis from ALK-rearranged More >